Margaretha C Minnaard1, Joris A H de Groot2, Rogier M Hopstaken2, Alwin Schierenberg2, Niek J de Wit2, Johannes B Reitsma2, Berna D L Broekhuizen2, Saskia F van Vugt2, Arie Knuistingh Neven2, Aleida W Graffelman2, Hasse Melbye2, Timothy H Rainer2, Johann Steurer2, Anette Holm2, Ralph Gonzales2, Geert-Jan Dinant2, Alma C van de Pol2, Theo J M Verheij2. 1. University Medical Center Utrecht (Minnaard, de Groot, Schierenberg, de Wit, Reitsma, Broekhuizen, van Vugt, van de Pol, Verheij), Julius Center for Health Sciences and Primary Care, Utrecht, the Netherlands; Saltro Diagnostic Center for Primary Care (Hopstaken), Utrecht, the Netherlands; Department of Public Health and Primary Care (Knuistingh Neven, Graffelman), Leiden University Medical Center, Leiden, the Netherlands; Department of Community Medicine (Melbye), UiT the Arctic University of Norway, Tromsø, Norway; Chinese University of Hong Kong (Rainer), Hong Kong, China; Horten Centre for Patient Oriented Research and Knowledge Transfer (Steurer), University Zurich, Zurich, Switzerland; Department of Infectious Diseases (Holm), Odense University Hospital, Odense, Denmark; Division of General Internal Medicine (Gonzales), University of California, San Francisco, Calif.; Department of Family Medicine (Dinant), CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, the Netherlands m.c.minnaard@umcutrecht.nl. 2. University Medical Center Utrecht (Minnaard, de Groot, Schierenberg, de Wit, Reitsma, Broekhuizen, van Vugt, van de Pol, Verheij), Julius Center for Health Sciences and Primary Care, Utrecht, the Netherlands; Saltro Diagnostic Center for Primary Care (Hopstaken), Utrecht, the Netherlands; Department of Public Health and Primary Care (Knuistingh Neven, Graffelman), Leiden University Medical Center, Leiden, the Netherlands; Department of Community Medicine (Melbye), UiT the Arctic University of Norway, Tromsø, Norway; Chinese University of Hong Kong (Rainer), Hong Kong, China; Horten Centre for Patient Oriented Research and Knowledge Transfer (Steurer), University Zurich, Zurich, Switzerland; Department of Infectious Diseases (Holm), Odense University Hospital, Odense, Denmark; Division of General Internal Medicine (Gonzales), University of California, San Francisco, Calif.; Department of Family Medicine (Dinant), CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, the Netherlands.
Abstract
BACKGROUND: C-reactive protein (CRP) is increasingly being included in the diagnostic work-up for community-acquired pneumonia in primary care. Its added diagnostic value beyond signs and symptoms, however, remains unclear. We conducted a meta-analysis of individual patient data to quantify the added value of CRP measurement. METHODS: We included studies of the diagnostic accuracy of CRP in adult outpatients with suspected lower respiratory tract infection. We contacted authors of eligible studies for inclusion of data and for additional data as needed. The value of adding CRP measurement to a basic signs-and-symptoms prediction model was assessed. Outcome measures were improvement in discrimination between patients with and without pneumonia in primary care and improvement in risk classification, both within the individual studies and across studies. RESULTS: Authors of 8 eligible studies (n = 5308) provided their data sets. In all of the data sets, discrimination between patients with and without pneumonia improved after CRP measurement was added to the prediction model (extended model), with a mean improvement in the area under the curve of 0.075 (range 0.02-0.18). In a hypothetical cohort of 1000 patients, the proportion of patients without pneumonia correctly classified at low risk increased from 28% to 36% in the extended model, and the proportion with pneumonia correctly classified at high risk increased from 63% to 70%. The number of patients with pneumonia classified at low risk did not change (n = 4). Overall, the proportion of patients assigned to the intermediate-risk category decreased from 56% to 51%. INTERPRETATION: Adding CRP measurement to the diagnostic work-up for suspected pneumonia in primary care improved the discrimination and risk classification of patients. However, it still left a substantial group of patients classified at intermediate risk, in which clinical decision-making remains challenging.
BACKGROUND:C-reactive protein (CRP) is increasingly being included in the diagnostic work-up for community-acquired pneumonia in primary care. Its added diagnostic value beyond signs and symptoms, however, remains unclear. We conducted a meta-analysis of individual patient data to quantify the added value of CRP measurement. METHODS: We included studies of the diagnostic accuracy of CRP in adult outpatients with suspected lower respiratory tract infection. We contacted authors of eligible studies for inclusion of data and for additional data as needed. The value of adding CRP measurement to a basic signs-and-symptoms prediction model was assessed. Outcome measures were improvement in discrimination between patients with and without pneumonia in primary care and improvement in risk classification, both within the individual studies and across studies. RESULTS: Authors of 8 eligible studies (n = 5308) provided their data sets. In all of the data sets, discrimination between patients with and without pneumonia improved after CRP measurement was added to the prediction model (extended model), with a mean improvement in the area under the curve of 0.075 (range 0.02-0.18). In a hypothetical cohort of 1000 patients, the proportion of patients without pneumonia correctly classified at low risk increased from 28% to 36% in the extended model, and the proportion with pneumonia correctly classified at high risk increased from 63% to 70%. The number of patients with pneumonia classified at low risk did not change (n = 4). Overall, the proportion of patients assigned to the intermediate-risk category decreased from 56% to 51%. INTERPRETATION: Adding CRP measurement to the diagnostic work-up for suspected pneumonia in primary care improved the discrimination and risk classification of patients. However, it still left a substantial group of patients classified at intermediate risk, in which clinical decision-making remains challenging.
Authors: M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij Journal: Clin Microbiol Infect Date: 2011-11 Impact factor: 8.067
Authors: Timothy H Rainer; Cangel P Y Chan; Man Fai Leung; Wingman Leung; Margaret Ip; Nelson Lee; George W H Cautherley; Colin A Graham; Dietmar Fuchs; Reinhard Renneberg Journal: J Infect Date: 2008-12-13 Impact factor: 6.072
Authors: Penny F Whiting; Anne W S Rutjes; Marie E Westwood; Susan Mallett; Jonathan J Deeks; Johannes B Reitsma; Mariska M G Leeflang; Jonathan A C Sterne; Patrick M M Bossuyt Journal: Ann Intern Med Date: 2011-10-18 Impact factor: 25.391
Authors: Johann Steurer; Ulrike Held; Anne Spaar; Birke Bausch; Marco Zoller; Roger Hunziker; Lucas M Bachmann Journal: BMC Med Date: 2011-05-13 Impact factor: 8.775
Authors: Saskia F van Vugt; Berna D L Broekhuizen; Christine Lammens; Nicolaas P A Zuithoff; Pim A de Jong; Samuel Coenen; Margareta Ieven; Chris C Butler; Herman Goossens; Paul Little; Theo J M Verheij Journal: BMJ Date: 2013-04-30
Authors: Tom H Boyles; Adrian Brink; Greg L Calligaro; Cheryl Cohen; Keertan Dheda; Gary Maartens; Guy A Richards; Richard van Zyl Smit; Clifford Smith; Sean Wasserman; Andrew C Whitelaw; Charles Feldman Journal: J Thorac Dis Date: 2017-06 Impact factor: 2.895
Authors: Paul Little; Beth Stuart; Nick Francis; Elaine Douglas; Sarah Tonkin-Crine; Sibyl Anthierens; Jochen W L Cals; Hasse Melbye; Miriam Santer; Michael Moore; Samuel Coenen; Chris C Butler; Kerenza Hood; Mark Kelson; Maciek Godycki-Cwirko; Artur Mierzecki; Antoni Torres; Carl Llor; Melanie Davies; Mark Mullee; Gilly O'Reilly; Alike van der Velden; Adam W A Geraghty; Herman Goossens; Theo Verheij; Lucy Yardley Journal: Ann Fam Med Date: 2019-03 Impact factor: 5.166
Authors: Malaika Schwartz; Victoria Hardy; Gina A Keppel; William Alto; Jaime Hornecker; Beth Robitaille; Jon Neher; John Holmes; M Ashworth Dirac; Allison M Cole; Matthew Thompson Journal: J Am Board Fam Med Date: 2017 Sep-Oct Impact factor: 2.657
Authors: A J M Loonen; C Kesarsing; R Kusters; M Hilbink; P C Wever; A J C van den Brule Journal: Eur J Clin Microbiol Infect Dis Date: 2017-03-29 Impact factor: 3.267
Authors: Adam T Hill; Philip M Gold; Ali A El Solh; Joshua P Metlay; Belinda Ireland; Richard S Irwin Journal: Chest Date: 2018-10-06 Impact factor: 9.410
Authors: Michael Klompas; Peter B Imrey; Pei-Chun Yu; Chanu Rhee; Abhishek Deshpande; Sarah Haessler; Marya D Zilberberg; Michael B Rothberg Journal: Infect Control Hosp Epidemiol Date: 2020-12-01 Impact factor: 6.520